Systech unveils game-changing turnkey solution for pharma rework and aggregation
In a groundbreaking development, Systech, a subsidiary of Markem-Imaje and Dover, has introduced a turnkey manual aggregation and rework solution tailored for pharmaceutical manufacturers, CMOs, CDMOs, re-packagers, and wholesalers.
More Stories
Eli Lilly enters $140M partnership with Radionetics Oncology
Eli Lilly has entered a strategic partnership with Radionetics Oncology, a biotechnology company focusing on the discovery and development of...
CatSci acquires Reach Separations to offer chromatography services
The deal was supported by Keensight Capital, a private equity manager focusing on pan-European investments in the technology and healthcare...
Tyra Biosciences announces proof of concept data in hypochondroplasia
Tyra Biosciences has released positive results from a preclinical proof of concept study testing its lead drug candidate, TYRA-300, in...
How is wearable tech enhancing sleep tracking in clinical trials?
Her insights, captured in the white paper "Closing the Gap in Our Understanding of Sleep Health with Fit-for-Purpose Wearable Digital...
Esteve invests €100 million in Spanish API manufacturing muscle
The construction project will be financed until 2026 by a €100 million ($108 million) investment by the company. The facilities,...
ALS treatment slows down disease progression by 36%
Results from the PARADIGM clinical trial have revealed that PrimeC, a treatment being developed by NeuroSense Therapeutics, was able to...